rivastigmine has been researched along with betadex in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carducci, CN; Kenndler, E; Lucangioli, SE; Masrian, E; Scioscia, SL; Tripodi, V | 1 |
| Degim, Z; Eşsiz, D; Mutlu, NB; Nacar, A; Yilmaz, S | 2 |
3 other study(ies) available for rivastigmine and betadex
| Article | Year |
|---|---|
Enantioselective separation of rivastigmine by capillary electrophoresis with cyclodextrines.
Topics: beta-Cyclodextrins; Electrophoresis, Capillary; Phenylcarbamates; Rivastigmine; Sensitivity and Specificity; Stereoisomerism | 2005 |
Investigation of liposome formulation effects on rivastigmine transport through human colonic adenocarcinoma cell line (CACO-2).
Topics: Absorption; Animals; beta-Cyclodextrins; Biological Transport, Active; Brain; Caco-2 Cells; Cell Survival; Chemistry, Pharmaceutical; Cholinesterase Inhibitors; Chromatography, High Pressure Liquid; Drug Compounding; Excipients; Humans; Liposomes; Male; Mice; Mice, Inbred BALB C; Microscopy, Electron, Transmission; Particle Size; Phenylcarbamates; Rivastigmine; Taurocholic Acid | 2010 |
New perspective for the treatment of Alzheimer diseases: liposomal rivastigmine formulations.
Topics: Alzheimer Disease; Animals; beta-Cyclodextrins; Biological Availability; Brain; Cell Line; Cholinesterase Inhibitors; Dogs; Drug Carriers; Drug Compounding; Drug Delivery Systems; Drug Stability; Humans; Liposomes; Male; Mice; Mice, Inbred BALB C; Microscopy, Electron, Transmission; Neuroprotective Agents; Particle Size; Phenylcarbamates; Rivastigmine; Taurocholic Acid | 2011 |